New hope for pancreatic cancer: drug combo aims to shrink tumors
Disease control
Not yet recruiting
This study tests whether adding a hedgehog inhibitor (NLM-001) and two immunotherapy drugs (botensilimab and balstilimab) to standard chemotherapy can shrink tumors better than chemotherapy alone in people with advanced pancreatic cancer that hasn't been treated yet. About 40 adu…
Phase: PHASE2 • Sponsor: Nelum Corp • Aim: Disease control
Last updated May 13, 2026 16:02 UTC